
Overview
Cord blood bank's fiscal 2025 revenue fell slightly from previous year
Company reported a net loss of $2.4 mln for fiscal 2025
Impairment charge of $4.4 mln recognized in Q4 due to inventory valuation changes
Outlook
Company did not provide specific financial guidance for future periods in press release
Result Drivers
IMPAIRMENT CHARGE - Co recognized a $4.4 mln impairment charge due to changes in inventory valuation
Company press release: ID:nBw61Z9m0a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
FY Revenue |
| $31.6 mln |
|
FY Net Income |
| -$2.4 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "hold"
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.